Xi Cheng
7Patents
1h-index
17Co-inventors
44Inventor score
Filing activity: Mar 21, 2012 → Mar 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10399971B2 | Compound for treating or preventing hyperuricemia or gout | Human Necessities | 1 | Active |
| US10875865B2 | URAT1 inhibitor and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11597725B2 | URAT1 inhibitor for promoting uric acid excretion | Chemistry; Metallurgy | 0 | Active |
| USRE50083E1 | URAT1 inhibitor and use thereof | General | 0 | Active |
| US10005744B2 | Compounds for the treatment or prevention of breast cancer | Human Necessities | 0 | Active |
| US8637013B2 | Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis | Chemistry; Metallurgy | 0 | Active |
| US11643405B2 | Compound for treatment or prevention of liver diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.